Correction to: Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing

被引：0
|
作者：
Rexhina Vlashi
Xingen Zhang
Haibo Li
Guiqian Chen
机构：
[1] Zhejiang Sci-Tech University,College of Life Science and Medicine, Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine
[2] Zhejiang Rongjun Hospital,Department of Orthopedics, Jiaxing Key Laboratory for Minimally Invasive Surgery in Orthopaedics & Skeletal Regenerative Medicine
[3] Ningbo Women and Children’s Hospital,The Central Laboratory of Birth Defects Prevention and Control
[4] Ningbo Women and Children’s Hospital,Ningbo Key Laboratory for the Prevention and Treatment of Embryogenic Diseases
来源：
Reviews in Endocrine and Metabolic Disorders | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：451 / 452
页数：1
相关论文
共 50 条
  • [21] CRISPR/Cas9 Essential Gene Editing in Drosophila
    Osadchiy, I. S.
    Kamalyan, S. O.
    Tumashova, K. Y.
    Georgiev, P. G.
    Maksimenko, O. G.
    ACTA NATURAE, 2023, 15 (02): : 70 - 74
  • [22] Optical Control of CRISPR/Cas9 Gene Editing
    Hemphill, James
    Borchardt, Erin K.
    Brown, Kalyn
    Asokan, Aravind
    Deiters, Alexander
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (17) : 5642 - 5645
  • [23] Spatiotemporal control of CRISPR/Cas9 gene editing
    Chenya Zhuo
    Jiabin Zhang
    Jung-Hwan Lee
    Ju Jiao
    Du Cheng
    Li Liu
    Hae-Won Kim
    Yu Tao
    Mingqiang Li
    Signal Transduction and Targeted Therapy, 6
  • [24] Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Kuruvilla, Joshua
    Sasmita, Andrew Octavian
    Ling, Anna Pick Kiong
    NEUROLOGICAL SCIENCES, 2018, 39 (11) : 1827 - 1835
  • [25] Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases
    Joshua Kuruvilla
    Andrew Octavian Sasmita
    Anna Pick Kiong Ling
    Neurological Sciences, 2018, 39 : 1827 - 1835
  • [26] GENE EDITING IN CHONDROCYTES USING CRISPR/CAS9
    Gibson, G.
    Yang, M.
    OSTEOARTHRITIS AND CARTILAGE, 2016, 24 : S2 - S3
  • [27] Spatiotemporal control of CRISPR/Cas9 gene editing
    Zhuo, Chenya
    Zhang, Jiabin
    Lee, Jung-Hwan
    Jiao, Ju
    Cheng, Du
    Liu, Li
    Kim, Hae-Won
    Tao, Yu
    Li, Mingqiang
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [28] Delivering on the therapeutic potential of CRISPR/cas9: development of an LNP-mediated genome editing therapeutic for the treatment of ATTR
    Chang, Y.
    HUMAN GENE THERAPY, 2018, 29 (12) : A15 - A15
  • [29] The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
    Abdelnour, Sameh A.
    Xie, Long
    Hassanin, Abdallah A.
    Zuo, Erwei
    Lu, Yangqing
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [30] Therapeutic gene editing strategies using CRISPR-Cas9 for the β-hemoglobinopathies
    Papizan, James B.
    Porter, Shaina N.
    Sharma, Akshay
    Pruett-Miller, Shondra M.
    JOURNAL OF BIOMEDICAL RESEARCH, 2021, 35 (02): : 115 - 134
12345